Kaleido Biosciences Inc (KLDO)

Kaleido Biosciences Inc (KLDO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4,262; returns 1 day +0.0%.

Kaleido Biosciences Inc. was a clinical-stage biotechnology company that focused on developing Microbiome Metabolic Therapies (MMT). The company's approach involved modulating the metabolic output and profile of the gut microbiome by influencing the function and composition of existing microbes, rather than introducing live microorganisms.

Groups KLDO belongs to

• Biotechnology
• Clinical Stage Biotech
• Clinical Stage
• Metabolic Disorders
• Healthcare
• Life Sciences
• Biopharmaceutical
• Pharmaceuticals
• Gastroenterology
• Digestive Health

KLDO financial model: income statement, cash flow and balance sheet